Farnaghi Saba, Crawford Ross, Xiao Yin, Prasadam Indira
Institute of Health and Biomedical Innovation, Science and Engineering Faculty, Queensland University of Technology, Brisbane, Qld, Australia.
Int J Rheum Dis. 2017 Feb;20(2):131-140. doi: 10.1111/1756-185X.13061. Epub 2017 Apr 5.
Several lines of research indicate that osteoarthritis (OA) is not only a joint disorder associated with mechanical stress and aging but also a 'metabolic syndrome' in which several risk factors work together to contribute to disease initiation and/or development. One such metabolic risk factor could be high cholesterol levels in the body. Even though high cholesterol level is a well-known risk factor for cardiovascular disorders, its possible role in musculoskeletal diseases, particularly OA, is not clear. The authors discuss the fundamental viewpoints on cholesterol involvement in the pathogenesis of OA, stressing the need for understanding the molecular mechanisms behind this association. This is the area of research needed to provide knowledge on how one should live to prevent OA development as well as to suggest new targets for drug therapy.
多项研究表明,骨关节炎(OA)不仅是一种与机械应力和衰老相关的关节疾病,也是一种“代谢综合征”,其中多种风险因素共同作用,促使疾病的发生和/或发展。体内高胆固醇水平可能就是这样一种代谢风险因素。尽管高胆固醇水平是心血管疾病的一个众所周知的风险因素,但其在肌肉骨骼疾病,尤其是骨关节炎中可能发挥的作用尚不清楚。作者讨论了胆固醇参与骨关节炎发病机制的基本观点,强调需要了解这种关联背后的分子机制。这是一个研究领域,旨在提供关于如何通过生活方式预防骨关节炎发展的知识,并为药物治疗提出新的靶点。